Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
23Andme Holding Co.
(NQ:
ME
)
0.2929
+0.0029 (+1.00%)
Streaming Delayed Price
Updated: 10:42 AM EDT, Oct 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about 23Andme Holding Co.
< Previous
1
2
3
4
5
6
7
Next >
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Via
Benzinga
7 Penny Stocks With the Biggest Chance of Blasting Off This Year
February 03, 2022
Penny stocks can rise quickly on relatively small catalysts, making them a great gamble. Here are a few that should rise.
Via
InvestorPlace
Why Jim Cramer Like NextEra Energy And Lincoln Electric?
January 21, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE:
Via
Benzinga
Why 23andMe Stock Jumped 16% Today
October 15, 2021
An analyst calls 23andMe's 11 million sample database unique and unprecedented.
Via
The Motley Fool
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?
January 18, 2022
Genetic testing company 23andMe Holding Co. (NASDAQ: ME) took the unconventional route of a SPAC deal to go public, and the stock hasn't gained much traction since it began...
Via
Benzinga
7 of The Best SPAC Stocks to Put on Your 2022 Watchlist
December 23, 2021
SPAC stocks may still be out of favor, but you'll still want to keep an eye on these seven picks with merger deals pending.
Via
InvestorPlace
Like Strong Balance Sheets? These 3 Stocks Are Loaded With Cash
December 10, 2021
With these kinds of resources, these companies are becoming less-risky investments.
Via
The Motley Fool
Why 23andMe Stock Dropped 29% in November
December 03, 2021
The company reported disappointing earnings results and has fallen victim to the recent sell-off in high-growth stocks.
Via
The Motley Fool
Why 23andMe Stock Crashed 10% Today
November 15, 2021
Last week's good news for the genetic data miner wasn't as good as it looked.
Via
The Motley Fool
Why 23andMe Stock Scored an 11% Gain Today
November 11, 2021
23andMe lost a lot less money than feared today -- so why is it sticking with a prediction for a full-sized loss for the year?
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021
November 15, 2021
Upgrades For Targa Resources Corp (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 11, 2021
Gainers Liquidia (NASDAQ:LQDA) stock inc...
Via
Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
Kevin Durant Launching A SPAC That Could Target Sports Or Cryptocurrency
November 03, 2021
One of the biggest National Basketball Association stars is dipping his toes into the SPAC market, becoming the latest celebrity or athlete to atta...
Via
Benzinga
Why 23andMe Rocketed 27.9% Higher in October
November 02, 2021
The genetics upstart is acquiring a telehealth platform.
Via
The Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
November SPAC Merger Calendar: Upcoming Votes, Earnings, Stocks To Watch
November 01, 2021
The month of November shows a continued slowdown in SPAC merger deal votes, but the calendar includes several multibillion-dollar deals. SPAC merger votes can act as a catalyst,...
Via
Benzinga
These 3 Unique Stocks Have Undeniable Long-Term Upside
October 29, 2021
These ideas are so unconventional that they just might work.
Via
The Motley Fool
Why 23andMe Stock Was Up More Than 9% on Tuesday
October 26, 2021
Investors may see potential in the company's proposed acquisition of telehealth company Lemonaid.
Via
The Motley Fool
Why 23andMe Stock Dropped Today
October 22, 2021
Fresh off its SPAC IPO, 23andMe is buying another company.
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs
October 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Athira Names Chief Operating Officer Mark Litton As Next CEO as Leen Kawas...
Via
Benzinga
Why 23andMe Stock Has Jumped 16% So Far This Week
October 21, 2021
A favorable mention on CNBC lit a fire underneath the biotech's stock this week.
Via
The Motley Fool
Jim Cramer Likes CVS And 23andMe, Considers This Stock 'Too Cheap'
October 20, 2021
On CNBC’s "Mad Money Lightnin...
Via
Benzinga
51 Biggest Movers From Friday
October 18, 2021
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it...
Via
Benzinga
23andMe Stock Could Be a Big Winner If This 1 Thing Happens
October 17, 2021
It needs to make money from something bigger than just its genetic test kits.
Via
The Motley Fool
ME Stock: 6 Things to Know About 23andMe as Shares Shoot Higher Today
October 15, 2021
23andMe (ME) stock is running higher on Friday as investors pile on with heavy trading thanks to a recent interview on CNBC.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
October 15, 2021
Gainers Statera BioPharma (NASDAQ:STAB) shares rose 16.9% to $3.32 during Friday's regular session. The market value of their outstanding shares is at $91.7 million....
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 15, 2021
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares moved upwards by 29.96% to $7.72 during Friday's pre-market session. The company's market cap stands at $20.8...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.